Gad Thomas Insider Trades

Insider Trading History

Track insider trading activity for Gad Thomas. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Y-Mabs Therapeutics
Y-Mabs Therapeutics YMAB
CHIEF BUSINESS OFFICER
Holding Value $0 0 shares
Last Trade
Sep 16, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$11.6M 1,348,054 shares
$8.61
$8.61
Y-Mabs Therapeutics
Y-Mabs Therapeutics YMAB
CHIEF BUSINESS OFFICER
Holding Value $0 0 shares
Last Trade
Sep 16, 2025 Sale (Tender)Reported as Tender on SEC Form 4.
$516k 60,000 shares
$8.60
$8.61
Y-Mabs Therapeutics
Y-Mabs Therapeutics YMAB
CHIEF BUSINESS OFFICER
Holding Value $2.63M 305,721 shares
Last Trade
Jun 03, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$502k 103,000 shares
$4.87
$8.61
Y-Mabs Therapeutics
Y-Mabs Therapeutics YMAB
CHIEF BUSINESS OFFICER
Holding Value $0 0 shares
Last Trade
Jun 03, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$502k 103,000 shares
$4.87
$8.61
Y-Mabs Therapeutics
Y-Mabs Therapeutics YMAB
CHIEF BUSINESS OFFICER
Holding Value $1.75M 202,721 shares
Last Trade
Mar 07, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$56.5k 10,810 shares
$5.23
$8.61
Y-Mabs Therapeutics
Y-Mabs Therapeutics YMAB
CHIEF BUSINESS OFFICER
Holding Value $1.84M 213,531 shares
Last Trade
Jan 17, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$394k 64,000 shares
$6.16
$8.61
Y-Mabs Therapeutics
Y-Mabs Therapeutics YMAB
CHIEF BUSINESS OFFICER
Holding Value $1.56M 181,531 shares
Last Trade
Sep 19, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$320k 22,831 shares
$14.00
$8.61
Y-Mabs Therapeutics
Y-Mabs Therapeutics YMAB
CHIEF BUSINESS OFFICER
Holding Value $1.23M 143,169 shares
Last Trade
Sep 19, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$320k 22,831 shares
$14.00
$8.61
Y-Mabs Therapeutics
Y-Mabs Therapeutics YMAB
CHIEF BUSINESS OFFICER
Holding Value $583k 67,681 shares
Last Trade
Sep 16, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$389k 30,000 shares
$12.97
$8.61
Y-Mabs Therapeutics
Y-Mabs Therapeutics YMAB
CHIEF BUSINESS OFFICER
Holding Value $841k 97,681 shares
Last Trade
Sep 13, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$876k 65,000 shares
$13.47
$8.61
Y-Mabs Therapeutics
Y-Mabs Therapeutics YMAB
CHIEF BUSINESS OFFICER
Holding Value $1.4M 162,681 shares
Last Trade
Jun 11, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$420k 35,000 shares
$12.00
$8.61
Y-Mabs Therapeutics
Y-Mabs Therapeutics YMAB
CHIEF BUSINESS OFFICER
Holding Value $1.7M 197,681 shares
Last Trade
Jun 10, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$421k 35,000 shares
$12.03
$8.61
Y-Mabs Therapeutics
Y-Mabs Therapeutics YMAB
CHIEF BUSINESS OFFICER
Holding Value $2M 232,681 shares
Last Trade
May 23, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$95.6k 7,351 shares
$13.00
$8.61
Y-Mabs Therapeutics
Y-Mabs Therapeutics YMAB
CHIEF BUSINESS OFFICER
Holding Value $2.07M 240,032 shares
Last Trade
May 21, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$300k 25,000 shares
$12.00
$8.61
Y-Mabs Therapeutics
Y-Mabs Therapeutics YMAB
CHIEF BUSINESS OFFICER
Holding Value $1.37M 158,700 shares
Last Trade
Mar 05, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$64.1k 3,900 shares
$16.44
$8.61
Y-Mabs Therapeutics
Y-Mabs Therapeutics YMAB
CHIEF BUSINESS OFFICER
Holding Value $1.4M 162,600 shares
Last Trade
Jan 18, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.3M 132,500 shares
$9.83
$8.61
Y-Mabs Therapeutics
Y-Mabs Therapeutics YMAB
Chief Business Officer
Holding Value $887k 103,000 shares
Last Trade
Dec 21, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$315k 50,000 shares
$6.29
$8.61
Y-Mabs Therapeutics
Y-Mabs Therapeutics YMAB
Chief Business Officer
Holding Value $1.21M 140,500 shares
Last Trade
Dec 21, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$315k 50,000 shares
$6.29
$8.61
Y-Mabs Therapeutics
Y-Mabs Therapeutics YMAB
Chief Business Officer
Holding Value $2.28M 265,032 shares
Last Trade
Dec 15, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$331k 50,000 shares
$6.61
$8.61
Y-Mabs Therapeutics
Y-Mabs Therapeutics YMAB
Chief Business Officer
Holding Value $2.71M 315,032 shares
Last Trade
Dec 14, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$342k 50,000 shares
$6.83
$8.61

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up